The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multicenter phase I/IIa study using T cell receptor gene therapy in metastatic melanoma.
 
Maartje W. Rohaan
No Relationships to Disclose
 
Joost van den Berg
No Relationships to Disclose
 
Raquel Gomez-Eerland
No Relationships to Disclose
 
Maaike van Zon
No Relationships to Disclose
 
Renate de Boer
No Relationships to Disclose
 
Eleonora A.M. Bakker
Research Funding - Neon Therapeutics
 
Loes M. Pronk
No Relationships to Disclose
 
Bart Van De Wiel
No Relationships to Disclose
 
Bastiaan Nuijen
No Relationships to Disclose
 
Marnix Geukes Foppen
No Relationships to Disclose
 
Johannes V. Van Thienen
Travel, Accommodations, Expenses - Roche
 
Christian U. Blank
Stock and Other Ownership Interests - Verastem
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Pfizer; Roche
 
John B. A. G. Haanen
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); MSD Oncology (Inst); Neon Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MSD (Inst)